SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-056994
Filing Date
2020-05-05
Accepted
2020-05-05 17:17:08
Documents
62
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20200331x10q.htm   iXBRL 10-Q 1676497
2 GRAPHIC iova-20200331x10q002.jpg GRAPHIC 66672
3 EX-31.1 iova-20200331xex31d1.htm EX-31.1 12052
4 EX-31.2 iova-20200331xex31d2.htm EX-31.2 11050
5 EX-32.1 iova-20200331xex32d1.htm EX-32.1 7857
6 EX-32.2 iova-20200331xex32d2.htm EX-32.2 7053
  Complete submission text file 0001104659-20-056994.txt   6724497

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA iova-20200331.xsd EX-101.SCH 43601
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iova-20200331_cal.xml EX-101.CAL 40847
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iova-20200331_def.xml EX-101.DEF 187118
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20200331_lab.xml EX-101.LAB 354068
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20200331_pre.xml EX-101.PRE 315967
21 EXTRACTED XBRL INSTANCE DOCUMENT iova-20200331x10q_htm.xml XML 1165873
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 20850051
SIC: 2836 Biological Products, (No Diagnostic Substances)